From Scourge to Cure: Tumour-Selective Viral Pathogenesis as a New Strategy against Cancer

Open Access

Review articles synthesize the best available evidence on a topic relevant to the pathogens community.

Carolina S. Ilkow,

Affiliation Centre for Innovative Cancer Therapeutics, Ottawa Health Research Institute, Ottawa, Ontario, Canada
⨯
Stephanie L. Swift,

Affiliation Swift Science Writing, Hamilton, Ontario, Canada
⨯
John C. Bell ,

Contributed equally to this work with: John C. Bell, Jean-Simon Diallo

* E-mail: jbell@ohri.ca

Affiliations Centre for Innovative Cancer Therapeutics, Ottawa Health Research Institute, Ottawa, Ontario, Canada, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada
⨯
Jean-Simon Diallo

Contributed equally to this work with: John C. Bell, Jean-Simon Diallo

Affiliations Centre for Innovative Cancer Therapeutics, Ottawa Health Research Institute, Ottawa, Ontario, Canada, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada
⨯

Reader Comments (1)

Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Viral replication
Is the Subject Area "Viral replication" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Oncolytic viruses
Is the Subject Area "Oncolytic viruses" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Interferons
Is the Subject Area "Interferons" applicable to this article?

Thanks for your feedback.